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IRAK4Endotoxin-induced uveitis (EIU) is an animal model of acute ocular inﬂammation for the study of
human endogenous anterior uveitis. The mechanisms accounting for the development of ocular
inﬂammation remain hazy. MicroRNAs (mi-RNAs) have been proposed as novel regulators of inﬂam-
mation. It remains unclear whether a microRNA-mediated regulatory mechanism is involved in
LPS-induced EIU. In this study, we report that miR-93 expression in the eyes of EIU rats and LPS-
stimulated macrophages is signiﬁcantly decreased. We also show that miR-93 inhibits NF-jB activa-
tion and pro-inﬂammatory cytokines by targeting IRAK4 expression. We further demonstrate that
miR-93 inhibits IRAK4 expression by binding directly to the 30-UTR of IRAK4. Our ﬁndings suggest
that miR-93 is a negative regulator of the immune response in EIU.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Endotoxin-induced uveitis (EIU) is an animal model of acute
ocular inﬂammation for the study of human endogenous anterior
uveitis, which in some cases has been linked to gram-negative
infections [1]. EIU is induced by the administration of lipopolysac-
charide (LPS), a component of Gram-negative bacterial outer
membranes [2]. Because uveitis frequently leads to severe vision
loss and blindness with retinal vasculitis, retinal detachment, and
glaucoma, it is important to elucidate further the mechanisms in
the development of ocular inﬂammation [3].
Upon binding of its ligand LPS, Toll-like receptor 4 (TLR4) re-
cruits the adaptor molecule myeloid differentiation primary re-
sponse gene 88 (MyD88) and members of the serine–threonine
kinases IL-1 receptor associated kinase (IRAK) family, including
IRAK1, IRAK2, IRAK4 and IRAK-M. In particular, IRAK4 is indispens-
able for activation of the MyD88-dependent pathway. Once phos-
phorylated, IRAKs dissociate from MyD88 and interact with
TRAF6. The IRAK–TRAF6 complex then interact with and activate
transforming-growth-factor-b-activated kinase 1 (TAK1). TAK1
phosphorylates IjB kinase a/b (IKKa/b) leading to IjB degradationand release of NF-kB, which give rise to the induction of inﬂamma-
tory genes such as TNF, IL-6, IL-1b, and MCP-1 [4–6]. All of those
cytokines contribute to the development of EIU, leading to the
break-down of the blood–ocular barrier and in the inﬁltration of
leukocytes. Hence, proper regulation of NF-jB signaling pathway
becomes a effective method to control EIU development.
The host inﬂammation response must be tightly controlled to
prevent harmful effects resulting from excessive activation.
MicroRNAs (miRNAs) are an abundant class of non-coding RNA
molecules that have been highly conserved during evolution,
usually 20–25 nucleotides. Once in their mature form, miRNAs
speciﬁcally bind to in the 30 untranslated regions (30 UTRs) of target
messenger RNA transcripts (mRNAs) leading to either mRNA deg-
radation or inhibition of translation [7–9]. A number of molecules
have been identiﬁed to regulate immune responses [10–12]. How-
ever, the complete patterns of miRNAs regulated and involved in
EIU remain to be fully elucidated. Here, we found that the expres-
sion of miR-93 was down-regulated in the eyes of rats which
developed EIU by administration of LPS. We also showed that
miR-93 mimic transfection resulted in an inhibition in NF-jB
activation and in pro-inﬂammatory cytokines, such as IL-1b, IL-6,
TNF-a and MCP-1. Further characterization of miR-93 revealed
that miR-93 inhibits IRAK4 expression by binding directly to the
30-UTR of IRAK4. Our ﬁndings demonstrate that level of miR-93
is down-regulated by LPS stimulation and miR-93 is a negative reg-
ulator of the immune response in EIU.
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2.1. Animals and induction of EIU
Eight-week-old male Wistar rats (160–220 g) were used. All
animals were maintained under a 12-h light/12-h dark cycle. Food
and water were supplied ad libitum. The ethics committee of
Shanghai Jiaotong University approved all surgical interventions
and animal care procedures, which are in compliance with the
ARVO statement for the use of Animals in Ophthalmic and Vision
Research. EIU was induced by a single subcutaneous injection of
LPS (200 lg/100 lL, Escherichia coli, 055:B5, Sigma–Aldrich, St.
Louis, MO, USA) in saline into the right hind footpad.
2.2. Aqueous humor analyses
Twenty-four hours after LPS injection, the aqueous humor
(AqH) was collected from the eyes immediately by an anterior
chamber puncture with a 30-gauge needle under a surgical micro-
scope. AqH was collected from both eyes of each animal and
pooled. For cell counting, the AqH samples were suspended in
the Trypan-blue solution (1:5), and applied to a hemocytometer.
The number of cells per ﬁeld (an equivalent of 0.1 L) was manually
counted under a light microscope (Olympus Optical Ltd., London,
UK), and the number of cells per microliter was obtained by aver-
aging the results of four ﬁelds from each sample.
2.3. Detection of miR-93 expression
Expression of miR-93 was detected by quantitative RT-PCR
based TaqMan MicroRNA assay (Applied Biosystems, Foster City,
USA) followed by manufacturer’s instructions. U6 snRNA was used
as an endogenous control.The miRNA levels were determined using
the 7500Fast System SDS software (Applied Biosystems, Foster
City, USA). The ddCt algorithm was used to calculate the relative
quantiﬁcation.
2.4. Detection of cytokine production
IL-1b, IL-6, TNF-a and MCP-1 production in the cell superna-
tants were measured with ELISA Kits (R&D) according to the man-
ufacturer’s protocols.
2.5. Computational predication of the miRNA targets
To further analyze the functions of miRNA-93, we used two
computational approaches, MicroRNA.org (www.microrna.org)
and targetscan (www.targetscan.org), to predict the targets of miR-
NA-93 in the TLR signaling pathways. mirSVR is an algorithm for
scoring and ranking the efﬁciency of miRanda-predicted microRNA
target sites. The scores can be interpreted as an empirical probabil-
ity of down-regulation of a single gene by a speciﬁc microRNA [13].
The targets that were predicted by both modules and contained
acceptable mirSVR down-regulation scores were selected for addi-
tional studies.
2.6. miR-93 mimics transfection
RAW 264.7 or 293T/TLR4 were transfected using Lipofectamine
RNAiMax Reagent (Invitrogen, Carlsbad, CA, USA) according to
manufacturer’s protocol. Brieﬂy, cells were transfected with mir-
Vana™ miR-93 mimic (M-miR-93) (Ambion) or with mirVana™
miRNA mimic Negative Control (C-miRNA) (Ambion) as validated
negative control. Successful transfection (>85% of all cells) was
conﬁrmed by visual ﬂuorescent analysis after transfection with
Block-iT™ Alexa Fluor ﬂuorescent oligo.2.7. Western blotting
To prepare total protein, 24 h post-transfection cells were col-
lected and lysed, and then subjected to SDS/PAGE gel, transferred
onto PVDF membrane, and blotted as reported [14]. For immuno-
blot analyses, all antibodies were obtained from Cell Signaling
Technology (USA)
2.8. Real-time PCR
Total RNA was extracted from cells using the TRIzol reagent
(Invitrogen). RNA then underwent reverse transcription using the
Prime Script RT Master Mix kit (TaKaRa). All gene transcripts were
measured by quantitative PCR with the SYBR Green Master Mix
(ABI), and the reactions were run on an ABI PRISM 7900HT Se-
quence Detection System (PE Applied Biosystems). Each sample
was ampliﬁed in triplicate. Data were analyzed using the SDS
software. The sequences of the primers for real-time PCR analysis
are as follows: HPRT, forward-TGCTCGAGATGTCATGAAGGAG, re-
verse-CAGAGGGCCACAATGTG; IL-1b, forward-GACCTGGGCTGTCC
TGATGA, reverse-GTGCTGCTGCGAGATTTGAA; IL-6, forward-TTCC
ATCCAGTTGCCTTCTTG, reverse-GAAGGCCGTGGTTGTCACC; TNF-a,
forward-CGTAGGCGATTACAGTCACGG, reverse-GACCAGGCTGTC
GCTACATCA; MCP-1 forward-CTGCTCAACTTGGCCATCTCT, re-
verse-GTGAGCCCAGAATGGTAATGTG; IRAK4, forward-CAAGTGA
TGGAGATGACCTCTGCTTAGT, reverse-TCTAGCAATAACTGAGGTTCA
CGGTGTT.
2.9. Luciferase assay
The 30UTR of mouse IRAK4 was ampliﬁed using PCR, and cloned
into a pGL3 vector (Promega, Madison, USA) to generate a Luc-WT-
30UTR vector. The following primers were used to clone IR-
AK430UTR: forward: 50-CTAGCTACTAGTATGGGGCTCATGTTCC-30;
and reverse: 50-CCGCTCGAGTGCCAGTTCAGAGGATACA-30. Deletion
of the miR-93 target site in the IRAK4 30UTR was performed using a
QuikChange mutagenesis kit (Stratagene, Heidelberg, Germany) to
generate the Luc-Mut-30UTR vector. After 24 h of transfection,
luciferase activity was measured using the Dual-Luciferase Repor-
ter Assay System (Promega) according to the manufacturer’s
instructions.
2.10. Statistical analysis
All experiments were repeated three times. Data was presented
as the mean ± S.D. Statistical signiﬁcance was determined by Stu-
dent’s t-test, with values of P < 0.05 considered to be statistically
signiﬁcant.3. Results
3.1. The expression of miR-93 is suppressed in the eyes of LPS-induced
EIU rats
It is reported that a number of microRNAs are induced by LPS,
which then regulate LPS-triggered inﬂammatory responses [15].
In order to test whether miR-93 is also involved in this immune re-
sponses, we detected the levels of miR-93 in eyes of EIU rats. We
induced EIU in rats with LPS (200 lg/rat) and then performed his-
tological staining with hematoxylin and eosin (H&E). Eyes in LPS-
treated rats consistently displayed severe hyperemia in the iris,
and the anterior chamber was hazy with inﬁltrated cells and some-
times with exudates (Fig. 1A). Cellular inﬁltration was examined in
aqueous humor 24 h after LPS injection. The actual cell numbers in
the aqueous humor of EIU were much higher than control (Fig. 1B).
Fig. 1. miR-93 is downregulated in the eyes of LPS-induced EIU rats. (A) Histopathologic features of inﬂammatory cell inﬁltration in the iris–ciliary bodies of LPS treated rats.
Rats was treated with 200 lg LPS for 24 h, and inﬂammatory cell inﬁltration was measured with H&E staining. (B) Cellular inﬁltration was examined in aqueous humor 24 h
after LPS injection. (C) miR-93 was measured in the eye of LPS treated rats by quantitative RT-PCR. U6 snRNA was used as an endogenous control. ⁄P < 0.05 (Student’s t-test).
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treated rats was signiﬁcantly reduced, which suggest that miR-93
might play a role in LPS-induced EIU.
3.2. miR-93 is downregulated in LPS-treated RAW 264.7 cells
To explore the mechanism of miR-93 in LPS-induced EIU, the le-
vel of miR-93 in LPS-treated RAW 264.7 cells was tested. miR-93
expression was dramatically inhibited upon LPS stimulation and
the down-regulation of miR-93 levels showed a dose-dependent
manner (Fig. 2A). Next, we measured miR-93 levels at different
time points of LPS stimulation. The down-regulation of miR-93 lev-
els upon LPS stimulation also showed a time-dependent manner
(Fig. 2B). These data indicated that miR-93 is a constitu-
tively expressing gene in RAW 264.7 cells and is downregulated
by LPS stimulation in time- and does-dependent manner, which
suggest miR-93 may play a part in LPS-mediated immune re-
sponses in macrophages.
3.3. miR-93 inhibits LPS-induced inﬂammatory cytokines production
LPS stimulation could activate NF-jB signaling and lead to cyto-
kines production such as IL-1b, IL-6, TNF-a and MCP-1 (Fig. 3A),
which all contribute to the development of EIU. To investigate
the role of miR-93 in cytokines production, miR-93 was over-ex-
pressed in RAW 264.7 cells. 48 h post-transfection, miR-93 levels
were measured by quantitative RT-PCR (Fig. 3B). After overexpres-
sion of miR-93 in Raw264.7, cells were treated with 1000 ng/mlLPS
for 24 h. The m RNA levels of cytokines including IL-1b, IL-6, TNFa
and MCP-1 was measured by RT-PCR. All of these cytokines were
greatly suppressed while overexpression of miR-93 (Fig. 3C–F).
3.4. miR-93. inhibits LPS-induced activation of NF-jB signaling
To further investigate the role of miR-93 in NF-jB activation,
RAW 264.7 cells were transfected with miR-93 for 24 h, thenFig. 2. miR-93 is downregulated in LPS-treated RAW 264.7 cells. (A) RAW 264.7 cells were
were measured by quantitative RT-PCR. U6 snRNA was used as an endogenous control.
given as means ± S.D. of three experiments. ⁄P < 0.05 (Student’s t-test). (B) RAW 264.7
measured by quantitative RT-PCR, and the relative expression normalized to U6 snRNAtreated with 1000 ng/ml LPS for another 24 h. The protein levels
of indicated proteins were measured by immunoblotting. The
phosphorylation of IKKa/b and IjB and nuclear translocation of
p65 which all represented NF-jB activation were dramatically re-
strained (Fig. 4A and B). We also measured the role of miR-93 in
NF-jB activation by dual-luciferase assay. 293T/TLR4 cells were
co-transfected with NF-kB-luc reporter plasmid, miR-93 mimics
along with indicated controls for 24 h, then treated with
1000 ng/mlLPS for another 24 h. Consistent with the immunoblot-
ting results, miR-93 suppressed NF-jB activation (Fig. 4C). We next
try to ﬁnd out the target of miR-93. Cells were treated as in Fig. 4A.
Western blot analysis showed the levels of TLR4 and Myd88 up-
stream of NF-jB signaling were not affected. However, the level
of IRAK4 was markedly suppressed (Fig. 4D). These data suggest
that miR-93 could suppress NF-jB signaling and the levels of
IRAK4 showed a negative correlation with miR-93.
3.5. IRAK4 is the molecular target of miR-93
To assess the role of miR-93 in NF-jb inhibition, a computa-
tional analysis was performed in order to identify putative target
genes for miR-93. The analysis has predicted miR-93 target se-
quences in 30-UTR of IRAK4 (Fig. 5A). We cloned the IRAK4
30-UTR sequence downstream of the luciferase reporter gene. Be-
sides, mutant IRAK4–30UTR included several mutation in miR-93
binding site which could not be targeted by miR-93 was also
cloned into the luciferase reporter plasmid (Fig. 5A). The dual-lucif-
erase reporter assay was performed in 293T cells. Cells were
co-transfected with a pRL-TK vector, the luciferase-wild type
IRAK4–30UTR (WT-30UTR) or the luciferase-mutant IRAK4–30UTR
(Mut-30UTR) reporter vector, as well as miR-93 or a control miRNA.
miR-93 reduced the WT-30UTR but not Mut-30UTR luciferase levels
(Fig. 5B). These data indicate that IRAK4 is the target of miR-93.
miR-93 downregulated the protein levels of IRAK4 but not the
mRNA levels (Fig. 5C and D). In addition, LPS could augment WT-
30UTR but not Mut-30UTR luciferase levels (Fig. 5E). These resultstreated with different doses of LPS for 24 h. Cells were harvested, and miR-93 levels
The relative expression of miR-93 normalized to U6 snRNA was shown. Values are
cells were treated with 1000 ng/ml LPS at indicated times. miR-93 levels were
was shown. ⁄P < 0.05 (Student’s t-test).
Fig. 3. miR-93 inhibits LPS-induced inﬂammatory cytokines production. (A) RAW 264.7 cells were treated with1000 ng/mlLPS for 24 h. The concentration of cytokines
including IL-1b, IL-6, TNFa and MCP-1 was measured by ELISA assay. ⁄P < 0.05 (Student’s t-test). (B) Cells were transfected with miR-93 mimics. At 48 h post-transfection,
miR-93 levels were measured by quantitative RT-PCR. The relative expression of miR-93 normalized to U6 snRNA was shown. ⁄P < 0.05 (Student’s t-test). (C–F) Cells were
transfected with miR-93 for 24 h, then treated with 1000 ng/ml LPS for another 24 h. The levels of cytokines including IL-1b, IL-6, TNFa and MCP-1 was measured by
quantitative RT-PCR. ⁄P < 0.05 (Student’s t-test).
Fig. 4. miR-93 inhibits LPS-induced activation of NF-jB signaling. (A) RAW 264.7 cells were transfected with miR-93 for 24 h, then treated with 1000 ng/ml LPS for another
24 h. The protein levels of indicated proteins were measured by immunoblotting. (B) Cells were treated as (A), and the nuclear fractions were extracted. Protein levels of
indicated proteins were measured by immunoblotting. (C) 293T/TLR4 cells were co-transfected with NF-jB-luc reporter plasmid, miR-93 mimics along with indicated
controls for 24 h, then treated with 1000 ng/mlLPS for another 24 h. The luciferase activity was measured by dual-luciferase assay. The relative luciferase activity was shown.
⁄P < 0.05 (Student’s t-test). (D) RAW 264.7 cells were transfected with miR-93 for 24 h, then treated with 10 lg/ml LPS for another 24 h. The levels of indicated proteins
upstream of NF-kB signaling were measured by immunoblotting.
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ing the 30-UTR of IRAK4 mRNA.
3.6. miR-93 inhibits LPS-induced inﬂammation through IRAK4
IRAK4 has been shown to play an essential role in Toll-like
receptor (TLR)-mediated signaling [6]. Knock down of IRAK4 using
siRNA signiﬁcantly inhibited the phosphorylation of IKKa/b andIjB (Fig. 6A) and NF-jB luciferase levels (Fig. 6B). We then ex-
plored whether IRAK4 could rescue the inhibition of NF-jB and
pro-inﬂammatory cytokines mediated by miR-93. Using dual-lucif-
erase assay, we found that overexpresion of IRAK4 along with miR-
93 followed by LPS stimulation totally rescued the inhibition of
NF-jB signaling mediated by miR-93 (Fig. 6C). Moreover, the levels
of the pro-inﬂammatory cytokines including IL-1b, IL-6, TNFa and
MCP-1 were also rescued (Fig. 6D–G). Taken together, these data
Fig. 5. IRAK4 is the molecular target of miR-93. (A) Schematic of miR-93 binding site in IRAK4 30UTR region, as detected by TargetScan. Mutant IRAK4–30UTR included several
mutation in miR-93 binding site. (B)The dual-luciferase reporter assay was performed in 293T cells. Cells were co-transfected with a pRL-TK vector, the luciferase-wild type
IRAK4–30UTR (WT-30UTR) or the luciferase-mutant IRAK4–30UTR (Mut-30UTR) reporter vector, as well as miR-93 or a control miRNA. The ratio of ﬁreﬂy activity/Renilla
activity represents luciferase activity. Bars indicate the relative luciferase activities of three experiments. ⁄P < 0.05 (Student’s t-test). (C) RAW 264.7 cells were transfected
with miR-93. Cells were harvested at indicated times, and IRAK4 levels were measured by immunoblotting. (D) RAW 264.7 cells were transfected with miR-93 at doses of 1 ll
(L, low) or 3 ll (H, high). IRAK4 mRNA levels were measured at 48 h post-transfection by quantitative RT-PCR. The relative IRAK4 mRNA levels normalizing to GAPDH were
shown. (E) 293T/TLR4 cells were transfected with WT-30UTR orMut-30UTR plasmid along with pRL-TK control plasmid followed by LPS treatment for 24 h. The luciferase
activity was measured by dual-luciferase assay. Bars indicate the relative luciferase activities of three experiments. ⁄P < 0.05 (Student’s t-test).
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the negative regulation of LPS-stimulated NF-jB activation and
pro-inﬂammatory cytokines production through targeting IRAK4.
4. Discussion
It is quite important to elucidate the mechanisms in the devel-
opment of ocular inﬂammation. Here, we found that miR-93
expression is markedly suppressed in the eyes of LPS-induced
EIU rats and LPS-treated RAW 264.7 cells. We also demonstrated
for the ﬁrst time that miR-93 targets the 30-UTR of IRAK4 and neg-
atively regulate LPS-stimulated NF-jB activation and pro-inﬂam-
matory cytokines production.
Emerging results indicate that TLR activation affects the expres-
sion of a few key miRNAs [16–18]. In this study, miR-93 was se-
lected for further study because of its
Downregulation in the eyes of EIU rats and in macrophages
stimulated with LPS. Studies have characterized miRNAs as ‘‘rheo-
stats’’ that make ﬁne-scale adjustments to protein output [19,20].
The downregulated expression of miR-93 indicates its role in a
more elaborated programmed feedback mechanism.
IRAK4 played a vital role for the LPS stimulated NF-jB activa-
tion. Patients with IRAK4 mutations are extremely susceptible to
recurrent bacterial infections [21]. Much effort has been devoted
towards the search for IRAK4 inhibitors, with the hope of develop-ing better anti-inﬂammatory therapies. miR-132 and miR-212
have been shown to prevent damaging consequences from the
overproduction of proinﬂammatory cytokines by targeting IRAK4
in PGN-induced tolerance [22]. The miRNA responsible for the reg-
ulation of IRAK4 in LPS-induced inﬂammation is not known. In this
article, IRAK4 mRNA was validated as a molecular target for
miR-93 in LPS treated macrophages. According to the TargetScan
algorithm, IRAK4 shares the same single 30-UTR binding site for
miR-93. The interaction between IRAK4 and miR-93 was analyzed
by luciferase assay using the vector containing the WT-30UTR or
the Mut-30UTR cloned downstream of a ﬁreﬂy luciferase reporter.
Luciferase expression was signiﬁcantly reduced when cotrans-
fected miR-93 with WT-30UTR plasmid, whereas no signiﬁcant
modulation was observed with Mut-30UTR. Furthermore, we found
that overexpresion of IRAK4 along with miR-93 followed by LPS
stimulation totally rescued the inhibition of NF-jB signaling med-
iated by miR-93. All these data strongly suggest that the IRAK4 was
the very target of miR-93 following LPS stimulation.
miR-93 has also been reported to be involved in brown adipo-
cyte differentiation by targeting Ppara [23], in murine Neural Stem
Cell Differentiation [24] and in the cell cycle pathway [25].
Although some of the molecular target is still unknown. It is unde-
niable that miR-93 is multifunctional and could have different
targets in different situations. It could also own several targets
even in the same circumstance. In this paper, the speciﬁcity for
Fig. 6. miR-93 inhibits LPS-induced inﬂammation through IRAK4. (A) RAW 264.7 cells were transfected with siIRAK4 for 24 h, then treated with 1000 ng/ml for another 24 h.
The protein levels of indicated proteins were measured by immunoblotting. (B) 293T/TLR4 cells were co-transfected with NF-jB-luc reporter plasmid, siIRAK4 along with
indicated controls for 24 h, then treated with 1000 ng/ml LPS for another 24 h. The luciferase activity was measured by dual-luciferase assay. The relative luciferase activity
was shown. ⁄P < 0.05 (Student’s t-test). (C) 293T/TLR4 cells were transfected with NF-jB-luc reporter plasmid, miR-93 or along with IRAK4 for 24 h, then treated with
1000 ng/ml LPS for another 24 h. The luciferase activity was measured by dual-luciferase assay. The relative luciferase activity was shown. ⁄P < 0.05 (Student’s t-test). (D–G)
RAW 264.7 cells were transfected with miR-93 or along with IRAK4 for 24 h, then treated with 1000 ng/ml for another 24 h. The concentration of cytokines including IL-1b, IL-
6, TNFa and MCP-1 was measured by ELISA assay. The relative levels of cytokines were shown. ⁄P < 0.05 (Student’s t-test).
Y. Xu et al. / FEBS Letters 588 (2014) 1692–1698 1697IRAK4 repression was demonstrated because miR-93 had no appar-
ent effect on TLR4 or Myd88 expression. Still, IRAK4 could totally
not partially rescue the inhibition of NF-jB signaling mediated
by miR-93. Taken together, regulation of IRAK4 is the major mech-
anism for miR-93 in LPS-induced inﬂammation.
In summary, we for the ﬁrst time highlight that miR-93 is
downregulated in the eyes of LPS-induced EIU rats and in macro-
phages treated by LPS. miR-93 suppressed NF-jB signaling and
pro-inﬂammatory cytokines IL-1, IL-6, TNF-a and MCP-1 produc-
tion. Further study demonstrates that miR-93 functions by target-
ing IRAK4 expression. All these results suggests that miR-93 may
be a negative regulator of LPS-stimulated immune response by
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